Enhance your practice with CME and tools that focus on the management of neurological conditions.
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026
Miami Beach, Florida
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey Lieberman, MD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP
Hannah Brown, MD
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Ashley Baker, MSN, PMHNP
Chia-Chun Chiang, MD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Nicholas Whipple, MD, MPH
How Daily Light Habits Influence Migraine in Adolescents
Carlyn Patterson Gentile, MD
Endogenous Pathways in Migraine Care: Harnessing the Body's Natural Systems
Adriana Della Pietra, MD
May 27, 2026 Miami Beach, Florida
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
Christyn Edmundson, MD
Neelam Goyal, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Aravindhan Veerapandiyan, MD
From Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Stephen Marder, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Challenges and Opportunities in Migraine Management
Yulia Orlova, MD
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Jerome Lisk, MD, MBA, M.S., FAAN
Michael Salvatore, PhD
Vicki Nejtek-Salvatore, PhD
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO
Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
Susan Scanland, MSN, CRNP, GNP-BC, CDP
Anthony J. Viera, MD, MPH
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Desiree Matthews, PMHNP-BC
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
Ashvini Keshavan, MRCP, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.